Pouyafar, Ayda <br/><br/>
Treatment of cancer stem cells from human colon adenocarcinoma cell line HT-29 with resveratrol and sulindac induced mesenchymal-endothelial transition rate.  [electronic resource] 

 -  Cell and tissue research  Jun 2019 
 - 377-388 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>1432-0878 
<br/><br/><label>Standard No.: </label>10.1007/s00441-019-02998-9  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Antigens, CD--metabolism<br/>Antineoplastic Agents--pharmacology<br/>Autophagy--drug effects<br/>Cadherins--metabolism<br/>Cell Differentiation--drug effects<br/>Chitinase-3-Like Protein 1--metabolism<br/>Epithelial-Mesenchymal Transition--drug effects<br/>HT29 Cells<br/>Humans<br/>N-Acetylgalactosaminyltransferases--metabolism<br/>Neoplastic Stem Cells--drug effects<br/>Resveratrol--pharmacology<br/>Signal Transduction--drug effects<br/>Sulindac--pharmacology<br/>Wnt3A Protein--antagonists & inhibitors<br/>von Willebrand Factor--metabolism